8-K: Aehr Test Systems Reports Mixed Q3 Results Amidst Order Delays, Reaffirms Full-Year Guidance
Quarterly Report
Aehr Test Systems announced its third quarter fiscal 2024 results, showing a decrease in revenue compared to the previous year but reaffirming its full-year financial guidance.
Summary
- Aehr Test Systems reported a net revenue of $7.6 million for the third quarter of fiscal year 2024, a decrease from $17.2 million in the same quarter of the previous year.
- The company experienced a GAAP net loss of $(1.5) million, or $(0.05) per diluted share, compared to a GAAP net income of $4.1 million, or $0.14 per diluted share, in the third quarter of fiscal 2023.
- Non-GAAP net loss was $(0.9) million, or $(0.03) per diluted share, compared to a non-GAAP net income of $4.7 million, or $0.16 per diluted share, in the third quarter of fiscal 2023.
- Bookings for the quarter were $24.5 million, and the backlog as of February 29, 2024, was $20 million.
- Total cash and cash equivalents were $47.6 million as of February 29, 2024, down from $50.5 million at November 30, 2023.
- For the first nine months of fiscal 2024, net revenue was $49.6 million, compared to $42.7 million in the first nine months of fiscal 2023.
- GAAP net income for the first nine months was $9.3 million, or $0.31 per diluted share, compared to $8.4 million, or $0.29 per diluted share, in the same period of the previous year.
- Non-GAAP net income for the first nine months was $11.0 million, or $0.37 per diluted share, compared to $10.5 million, or $0.36 per diluted share, in the same period of the previous year.
- Cash provided by operations was $0.5 million for the first nine months of fiscal 2024.
- The company is reiterating its full-year guidance for total revenue of greater than $65 million and GAAP net income of approximately $11 million or more, or $0.38 per diluted share.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly negative due to the significant revenue decline and net loss in Q3, offset by the reaffirmation of full-year guidance and new customer wins. The delays in orders are a concern, but the long-term outlook remains positive.
Positives
- The company secured $24.5 million in bookings for the quarter.
- Aehr has a backlog of $20 million.
- The company has $47.6 million in cash and cash equivalents.
- Aehr secured a new customer for its FOX-NP solution, a multi-billion dollar semiconductor company.
- The company is seeing increased customer engagement in key markets.
- Aehr has not lost a potential customer after demonstrating their FOX wafer level test and burn-in solution.
- The company is reiterating its full-year guidance for total revenue of greater than $65 million and GAAP net income of approximately $11 million or more.
Negatives
- Third quarter revenue decreased significantly to $7.6 million from $17.2 million year-over-year.
- The company reported a GAAP net loss of $(1.5) million for the third quarter, compared to a net income of $4.1 million in the same period last year.
- Non-GAAP net loss for the quarter was $(0.9) million, compared to a non-GAAP net income of $4.7 million in the prior year.
- Cash and cash equivalents decreased from $50.5 million at November 30, 2023 to $47.6 million at February 29, 2024.
Risks
- The company experienced delays in wafer level burn-in system orders for silicon carbide semiconductor devices used in electric vehicles.
- The semiconductor industry is subject to market fluctuations and economic conditions.
- The company's ability to secure new customer engagements and orders is subject to various factors.
- The company's financial performance is dependent on the timing of revenue recognition.
Future Outlook
Aehr is encouraged by increasing engagements with current and potential customers and the long-term growth opportunities in key markets. The company is focused on the qualification process with new customers and expects to discuss new market segments in the coming months. They are reiterating their full year guidance of greater than $65 million in revenue and at least $11 million in net income.
Management Comments
- Gayn Erickson, President and CEO, noted that the third quarter results reflect delays in wafer level burn-in system orders for silicon carbide semiconductor devices used in electric vehicles.
- Management stated they still expect to finish this fiscal year with annual revenue that is near or above their full year record.
- Management highlighted an initial order for their FOX-NP solution from a new multi-billion dollar per year global semiconductor company.
- Management indicated they are in continued engagements with well over a dozen silicon carbide suppliers.
- Management believes the key markets Aehr is addressing have significant growth opportunities that will expand this year and throughout this decade.
- Management noted a recent strengthening in the silicon carbide market for electric vehicles outside the US.
Industry Context
The announcement comes amid a broader trend of increasing demand for semiconductor testing and burn-in solutions, driven by the growth in electric vehicles, AI, green energy, and IoT. The company is positioning itself to capitalize on these trends with its FOX platform and is seeing increased customer engagement in these markets. The semiconductor industry is expected to grow from $600 million in 2022 to over $1 trillion at or around 2030.
Comparison to Industry Standards
- Aehr's Q3 revenue decline contrasts with the overall semiconductor industry's projected growth, suggesting potential market share shifts or specific challenges within their niche.
- While companies like Teradyne and Advantest also provide semiconductor testing equipment, Aehr focuses on wafer-level burn-in, a specialized area that is seeing increased demand due to the rise of silicon carbide and other advanced materials.
- The company's focus on silicon carbide for electric vehicles aligns with industry trends, but the reported delays indicate potential challenges in converting this demand into immediate revenue.
- Aehr's backlog of $20 million is a positive sign, but it needs to be converted into revenue to meet its full-year guidance.
- The company's cash position of $47.6 million provides a buffer, but it needs to manage its expenses and investments to ensure long-term sustainability.
Stakeholder Impact
- Shareholders may be concerned about the decreased revenue and net loss in the third quarter.
- Employees may be impacted by the company's financial performance.
- Customers may be affected by the delays in orders.
- Suppliers may be impacted by the company's financial performance.
- Creditors may be concerned about the company's financial performance.
Next Steps
- Aehr will host a conference call and webcast to discuss its third quarter fiscal 2024 operating results.
- The company will continue to focus on the qualification process with new customers.
- Aehr will continue to engage with silicon carbide suppliers and electric vehicle suppliers.
- The company will provide additional details on their visits with silicon carbide and electric vehicle suppliers during their earnings call.
- Aehr will continue to invest in the FOX platform to address new market segments.
Key Dates
| Date | Description |
|---|---|
| February 28, 2023 | Comparative period for financial results in the prior fiscal year. |
| November 30, 2023 | Date of previous quarter's cash and cash equivalents balance. |
| February 29, 2024 | End date of the third quarter of fiscal year 2024. |
| April 9, 2024 | Date of the press release and 8-K filing. |
| May 31, 2024 | End of fiscal year 2024. |
Keywords
semiconductor test, burn-in equipment, silicon carbide, wafer level test, FOX-NP, FOX-XP, electric vehicles, semiconductor devices, financial results, revenue, net income, bookings, backlog
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.